StockNews.AI
PM
CNBC
202 days

How Zyn helped Philip Morris International make a comeback

1. Zyn's success supports Philip Morris amidst declining cigarette sales. 2. FDA authorized 20 Zyn products, reducing risk compared to traditional tobacco. 3. Zyn shipments reached 238 million cans in 2022, expected to double in 2024. 4. Philip Morris aims for 2/3 of revenue from smoke-free products by 2030. 5. Recent investments for production expansion signify commitment to smokeless products.

3m saved
Insight
Article

FAQ

Why Very Bullish?

Zyn's positive outlook and FDA approval enhance PM's market position and revenue potential.

How important is it?

The article highlights key growth drivers for PM, significantly impacting their market trajectory.

Why Long Term?

Continued growth in smokeless products will provide sustainable revenue for PM.

Related Companies

Related News